A detailed history of Wellington Management Group LLP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 4,309,405 shares of KYMR stock, worth $200 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,309,405
Previous 4,293,697 0.37%
Holding current value
$200 Million
Previous $173 Million 25.47%
% of portfolio
0.02%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$29.85 - $39.42 $468,883 - $619,209
15,708 Added 0.37%
4,309,405 $129 Million
Q1 2024

May 15, 2024

BUY
$22.9 - $43.57 $98.3 Million - $187 Million
4,293,697 New
4,293,697 $173 Million
Q4 2023

Feb 12, 2024

BUY
$10.97 - $26.84 $52.8 Million - $129 Million
4,815,558 New
4,815,558 $123 Million
Q3 2023

Nov 14, 2023

BUY
$13.9 - $23.88 $8,979 - $15,426
646 Added 0.01%
4,823,329 $67 Million
Q2 2023

Aug 14, 2023

BUY
$22.4 - $34.92 $11.9 Million - $18.6 Million
531,665 Added 12.39%
4,822,683 $111 Million
Q1 2023

May 12, 2023

SELL
$24.84 - $38.75 $7.45 Million - $11.6 Million
-300,071 Reduced 6.54%
4,291,018 $127 Million
Q4 2022

Feb 13, 2023

BUY
$19.57 - $30.92 $23.1 Million - $36.5 Million
1,180,703 Added 34.62%
4,591,089 $115 Million
Q3 2022

Nov 14, 2022

SELL
$20.91 - $34.27 $34 Million - $55.7 Million
-1,624,554 Reduced 32.27%
3,410,386 $74.2 Million
Q2 2022

Aug 15, 2022

BUY
$14.13 - $42.55 $25.6 Million - $77 Million
1,809,191 Added 56.09%
5,034,940 $99.1 Million
Q1 2022

May 16, 2022

BUY
$35.3 - $64.68 $18.7 Million - $34.3 Million
530,935 Added 19.7%
3,225,749 $137 Million
Q4 2021

Feb 11, 2022

BUY
$49.91 - $65.56 $11.3 Million - $14.9 Million
226,879 Added 9.19%
2,694,814 $171 Million
Q3 2021

Nov 15, 2021

BUY
$47.8 - $66.66 $78.4 Million - $109 Million
1,639,994 Added 198.08%
2,467,935 $145 Million
Q2 2021

Aug 16, 2021

BUY
$31.08 - $51.95 $4.93 Million - $8.24 Million
158,648 Added 23.7%
827,941 $40.2 Million
Q1 2021

May 17, 2021

SELL
$35.64 - $85.46 $36.4 Million - $87.3 Million
-1,021,286 Reduced 60.41%
669,293 $26 Million
Q4 2020

Feb 12, 2021

SELL
$28.07 - $87.83 $2.07 Million - $6.46 Million
-73,605 Reduced 4.17%
1,690,579 $104 Million
Q3 2020

Nov 16, 2020

BUY
$26.1 - $33.28 $46 Million - $58.7 Million
1,764,184 New
1,764,184 $55.8 Million

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.54B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.